CHA sent a comment letter to the FDA on draft guidance that recommends how and when manufacturers provide additional information in drug shortage notifications to the agency. Our letter urges the FDA to address the specific challenges facing the pediatric drug supply chain through transparency requirements, developing proactive shortage mitigation plans, and ensuring an accounting of pediatric drugs on the FDA drug shortages list.
CHA Submits Comments on FDA Drug Shortage Guidance
Children’s Hospital Association sends a comment letter to the FDA on draft drug shortage guidance to highlight the need for an efficient pediatric supply chain.
Related Content
7 Ways Pediatric Care Is Different From Adult Care
Children’s health care operates under a different set of clinical, financial, and operational realities.
June 16, 2026
Families and Children's Hospitals Urge Congressional Action on Pediatric Health Priorities
Family Advocacy Day brings families to Capitol Hill to highlight growing barriers to care, from Medicaid coverage to workforce shortages and youth mental health.
June 02, 2026
Where Kids’ Stories Help Guide Policy
Family Advocacy Day empowers children to share their experiences and help shape the future of pediatric care.
June 01, 2026
